News releases

2021

Jun 16, 2021 M&A/partnership

M&A/partnership

Notice Regarding Agreement for Business Alliance with Morimoto-Pharma Co., Ltd.(77 KB)
Jun 16, 2021 product/service

product/service

Notice Regarding Approval of Partial Amendments to Indications, Dosage and Administration of DULOXETINE Capsules 20mg/30mg “KMP” for KYOSOMIRAI PHARMA(126 KB)
May 26, 2021 M&A/partnership

M&A/partnership

Notice Regarding Business Succession by a Subsidiary(116 KB)
May 26, 2021 M&A/partnership

M&A/partnership

Notice Regarding Underwriting of Capital Increase Through Third-Party Allotment Conducted by HAPINE Life Ikkou Corporation(131 KB)
May 25, 2021 corporate

corporate

Notice Regarding Change of Representative Director(142 KB)
May 14, 2021 performance

performance

Summary of Consolidated Financial Results of Fiscal Year Ended March 31, 2021(1 MB)
May 14, 2021 corporate

corporate

Notice Regarding Decision on the Candidates for Directors(66 KB)
May 14, 2021 product/service

product/service

Notice RegardingLaunch of1 Ingredient/ 2 Products of Generic Drugs for KYOSOMIRAI PHARMA(118 KB)
Apr 23, 2021 performance

performance

Notice Regarding Full-Year Earnings Forecasts for Fiscal Year Ended March 2021 and Recording of Extraordinary Loss(30 KB)
Apr 16, 2021 other

other

Notice Regarding Disclosure of “Names of Drug Product Manufacturers” for Products that KYOSOMIRAI PHARMA Holds Marketing Approvals(107 KB)
Apr 05, 2021 other

other

Notice Regarding Free Provision of Nafamostat Mesilate Products(106 KB)
Mar 26, 2021 M&A/partnership

M&A/partnership

Notice Regarding a Merger of Three Transport Business Companies and a Change of the Name to “KYOSO LOGISTICS CO., LTD.”(137 KB)
Mar 25, 2021 product/service

product/service

Notice Regarding Launch of 1 Ingredient / 2 Products of Generic Drugs for KYOSOMIRAI PHARMA(133 KB)
Mar 11, 2021 other

other

Notice of the Posting of a Gain on Sale of Investment Securities (Extraordinary Income)(64 KB)